CD40LG and COVID-19: These findings show that the Abs directed against CPEs #7, #11 and #111, both singly and in combination, inhibited pseudo-virus infection in an additive, but not a synergistic, manner; however, these inhibitory activities were over 10-times weaker than those of the IgG and IgM from patients convalescing from severe COVID-19.